Valeant has rebranded as Bausch Health. Insiders are buying aggressively – some taking advantage of a ‘buy one share, get one free’ deal
Chairman Joseph C. Papa and CFO Paul Herendeen of Bausch Health Companies (NYSE:BHC) purchased a total of 40,000 BHC shares on Sept. 14 at an average price of $22.39, spending $896,000. And thanks to a “Matching Share Program” offered by Bausch Health, the insiders were granted an additional 40,000 shares. The granted shares are restricted – 1/3 of the granted shares vest on each of the three anniversaries of the date granted. If the insider leaves the company, he or she would forfeit unvested shares.